In its Series A round, Scimplify, a platform for sourcing & manufacturing specialty chemicals, raised approximately $7 million from new and existing investors.

The board at Scimplify has passed an exceptional resolution to give 17,514 Series A CCPS at an issue cost of Rs.33, 676 each to raise Rs.59 crore or $7 million, its administrative documenting with the Registrar of Companies shows.

With Rs.24.7 million, Omnivore led the round, while Bertelsmann, 3One4 Capital, and Beenext Asia contributed Rs.13.56 million, Rs.5.6 million, and Rs.14.82 million, respectively.

In June, Entarckr was the first to discuss Scimplify's Series A. The startup has raised around $11 million to date including its $3.67 million seed round from 3one4 Capital and Beenext last year.

The startup data intelligence platform TheKredible claims that Scimplify's post-allotment value is approximately Rs 320 crore, or $39 million. Scimplify is a B2B fulfillment platform that operates throughout the product life cycle, from contract research to commercial chemical manufacturing in pharmaceutical, personal care, and agrochemical industries.

It was founded in 2023 by Salil Srivastava and Sachin Santhosh. Emulsifiers, plant growth stimulators, biostimulants, adjuvants, and biofertilizers are among the products that the company offers, as stated on its website.

The Bengaluru-based firm competes with Atomgrid, which brought $1.2 million up in its seed round driven by Merak Adventures in May this year. Another major player in the market, Covvalent, raised $4.3 million under the direction of Nexus Venture Partners.

Scimplify is a science-first platform for cutting edge sourcing and manufacturing of speciality chemicals.